Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial.
Saved in:
| Title: | Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial. |
|---|---|
| Authors: | Connor MJ; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK. Electronic address: m.connor@imperial.ac.uk., Shah TT; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Sukumar J; Imperial Clinical Trials Unit (ICTU), School of Public Health, Faculty of Medicine, Imperial College London, London, UK., Basak D; Department of Oncology, Imperial College Healthcare NHS Foundation Trust, Charing Cross Hospital, London, UK., Fiorentino F; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Heath C; Department of Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Horan G; Department of Oncology, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust & The Cancer Centre, Addenbrooke's Hospital, Cambridge, UK., Johnson N; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Khoo V; Department of Oncology, The Royal Marsden Hospital, London, UK., Khoubehi B; Department of Urology, Chelsea & Westminster NHS Foundation Trust, London, UK., Klimowska-Nassar N; Imperial Clinical Trials Unit (ICTU), School of Public Health, Faculty of Medicine, Imperial College London, London, UK., Mangar S; Department of Oncology, Imperial College Healthcare NHS Foundation Trust, Charing Cross Hospital, London, UK., McGrath J; Department of Urology, Royal Devon and Exeter NHS Foundation Trust, Oncology, Exeter, UK., Nohpal de la Rosa C; Imperial Clinical Trials Unit (ICTU), School of Public Health, Faculty of Medicine, Imperial College London, London, UK., Price D; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Rai B; Department of Urology, Newcastle Freeman Hospital, Newcastle, UK., Sarwar N; Department of Oncology, Imperial College Healthcare NHS Foundation Trust, Charing Cross Hospital, London, UK., Smith A; Department of Histopathology, Imperial College Healthcare NHS Foundation Trust, Charing Cross Hospital, London, UK., Staffurth JN; Department of Oncology and Radiotherapy, Cardiff University, Cardiff, UK., Tam H; Department of Radiology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Thippu Jayaprakash K; Department of Oncology, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust & The Cancer Centre, Addenbrooke's Hospital, Cambridge, UK., Winkler M; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Dudderidge T; Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Ahmed HU; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK. |
| Corporate Authors: | IP2-ATLANTA Trial Investigators |
| Source: | European urology oncology [Eur Urol Oncol] 2026 Apr; Vol. 9 (2), pp. 276-285. Date of Electronic Publication: 2025 Jun 13. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40517058 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Connor+MJ%22">Connor MJ</searchLink>; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK. Electronic address: m.connor@imperial.ac.uk.<br /><searchLink fieldCode="AU" term="%22Shah+TT%22">Shah TT</searchLink>; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Sukumar+J%22">Sukumar J</searchLink>; Imperial Clinical Trials Unit (ICTU), School of Public Health, Faculty of Medicine, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Basak+D%22">Basak D</searchLink>; Department of Oncology, Imperial College Healthcare NHS Foundation Trust, Charing Cross Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Fiorentino+F%22">Fiorentino F</searchLink>; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Heath+C%22">Heath C</searchLink>; Department of Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Horan+G%22">Horan G</searchLink>; Department of Oncology, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust & The Cancer Centre, Addenbrooke's Hospital, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Johnson+N%22">Johnson N</searchLink>; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Khoo+V%22">Khoo V</searchLink>; Department of Oncology, The Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Khoubehi+B%22">Khoubehi B</searchLink>; Department of Urology, Chelsea & Westminster NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Klimowska-Nassar+N%22">Klimowska-Nassar N</searchLink>; Imperial Clinical Trials Unit (ICTU), School of Public Health, Faculty of Medicine, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Mangar+S%22">Mangar S</searchLink>; Department of Oncology, Imperial College Healthcare NHS Foundation Trust, Charing Cross Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22McGrath+J%22">McGrath J</searchLink>; Department of Urology, Royal Devon and Exeter NHS Foundation Trust, Oncology, Exeter, UK.<br /><searchLink fieldCode="AU" term="%22Nohpal+de+la+Rosa+C%22">Nohpal de la Rosa C</searchLink>; Imperial Clinical Trials Unit (ICTU), School of Public Health, Faculty of Medicine, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Price+D%22">Price D</searchLink>; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Rai+B%22">Rai B</searchLink>; Department of Urology, Newcastle Freeman Hospital, Newcastle, UK.<br /><searchLink fieldCode="AU" term="%22Sarwar+N%22">Sarwar N</searchLink>; Department of Oncology, Imperial College Healthcare NHS Foundation Trust, Charing Cross Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Smith+A%22">Smith A</searchLink>; Department of Histopathology, Imperial College Healthcare NHS Foundation Trust, Charing Cross Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Staffurth+JN%22">Staffurth JN</searchLink>; Department of Oncology and Radiotherapy, Cardiff University, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Tam+H%22">Tam H</searchLink>; Department of Radiology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Thippu+Jayaprakash+K%22">Thippu Jayaprakash K</searchLink>; Department of Oncology, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust & The Cancer Centre, Addenbrooke's Hospital, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Winkler+M%22">Winkler M</searchLink>; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Dudderidge+T%22">Dudderidge T</searchLink>; Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Ahmed+HU%22">Ahmed HU</searchLink>; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22IP2-ATLANTA+Trial+Investigators%22">IP2-ATLANTA Trial Investigators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101724904%22">European urology oncology</searchLink> [Eur Urol Oncol] 2026 Apr; Vol. 9 (2), pp. 276-285. <i>Date of Electronic Publication: </i>2025 Jun 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101724904 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2588-9311 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225889311%22">25889311 </searchLink><i>NLM ISO Abbreviation: </i>Eur Urol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40517058 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.euo.2025.05.010 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 276 Titles: – TitleFull: Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Connor MJ – PersonEntity: Name: NameFull: Shah TT – PersonEntity: Name: NameFull: Sukumar J – PersonEntity: Name: NameFull: Basak D – PersonEntity: Name: NameFull: Fiorentino F – PersonEntity: Name: NameFull: Heath C – PersonEntity: Name: NameFull: Horan G – PersonEntity: Name: NameFull: Johnson N – PersonEntity: Name: NameFull: Khoo V – PersonEntity: Name: NameFull: Khoubehi B – PersonEntity: Name: NameFull: Klimowska-Nassar N – PersonEntity: Name: NameFull: Mangar S – PersonEntity: Name: NameFull: McGrath J – PersonEntity: Name: NameFull: Nohpal de la Rosa C – PersonEntity: Name: NameFull: Price D – PersonEntity: Name: NameFull: Rai B – PersonEntity: Name: NameFull: Sarwar N – PersonEntity: Name: NameFull: Smith A – PersonEntity: Name: NameFull: Staffurth JN – PersonEntity: Name: NameFull: Tam H – PersonEntity: Name: NameFull: Thippu Jayaprakash K – PersonEntity: Name: NameFull: Winkler M – PersonEntity: Name: NameFull: Dudderidge T – PersonEntity: Name: NameFull: Ahmed HU IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2026 Apr Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2588-9311 Numbering: – Type: volume Value: 9 – Type: issue Value: 2 Titles: – TitleFull: European urology oncology Type: main |
| ResultId | 1 |
